Cargando…

The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways

BACKGROUND: Myogenesis is a highly regulated process ending with the formation of myotubes, the precursors of skeletal muscle fibers. Differentiation of myoblasts into myotubes is controlled by myogenic regulatory factors (MRFs) that act as terminal effectors of signaling cascades involved in the te...

Descripción completa

Detalles Bibliográficos
Autores principales: Coudert, L., Osseni, A., Gangloff, Y. G., Schaeffer, L., Leblanc, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323235/
https://www.ncbi.nlm.nih.gov/pubmed/34330273
http://dx.doi.org/10.1186/s12915-021-01091-4
_version_ 1783731201727528960
author Coudert, L.
Osseni, A.
Gangloff, Y. G.
Schaeffer, L.
Leblanc, P.
author_facet Coudert, L.
Osseni, A.
Gangloff, Y. G.
Schaeffer, L.
Leblanc, P.
author_sort Coudert, L.
collection PubMed
description BACKGROUND: Myogenesis is a highly regulated process ending with the formation of myotubes, the precursors of skeletal muscle fibers. Differentiation of myoblasts into myotubes is controlled by myogenic regulatory factors (MRFs) that act as terminal effectors of signaling cascades involved in the temporal and spatial regulation of muscle development. Such signaling cascades converge and are controlled at the level of intracellular trafficking, but the mechanisms by which myogenesis is regulated by the endosomal machinery and trafficking is largely unexplored. The Endosomal Sorting Complex Required for Transport (ESCRT) machinery composed of four complexes ESCRT-0 to ESCRT-III regulates the biogenesis and trafficking of endosomes as well as the associated signaling and degradation pathways. Here, we investigate its role in regulating myogenesis. RESULTS: We uncovered a new function of the ESCRT-0 hepatocyte growth factor-regulated tyrosine kinase substrate Hrs/Hgs component in the regulation of myogenesis. Hrs depletion strongly impairs the differentiation of murine and human myoblasts. In the C2C12 murine myogenic cell line, inhibition of differentiation was attributed to impaired MRF in the early steps of differentiation. This alteration is associated with an upregulation of the MEK/ERK signaling pathway and a downregulation of the Akt2 signaling both leading to the inhibition of differentiation. The myogenic repressors FOXO1 as well as GSK3β were also found to be both activated when Hrs was absent. Inhibition of the MEK/ERK pathway or of GSK3β by the U0126 or azakenpaullone compounds respectively significantly restores the impaired differentiation observed in Hrs-depleted cells. In addition, functional autophagy that is required for myogenesis was also found to be strongly inhibited. CONCLUSIONS: We show for the first time that Hrs/Hgs is a master regulator that modulates myogenesis at different levels through the control of trafficking, signaling, and degradation pathways. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-021-01091-4.
format Online
Article
Text
id pubmed-8323235
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83232352021-07-30 The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways Coudert, L. Osseni, A. Gangloff, Y. G. Schaeffer, L. Leblanc, P. BMC Biol Research Article BACKGROUND: Myogenesis is a highly regulated process ending with the formation of myotubes, the precursors of skeletal muscle fibers. Differentiation of myoblasts into myotubes is controlled by myogenic regulatory factors (MRFs) that act as terminal effectors of signaling cascades involved in the temporal and spatial regulation of muscle development. Such signaling cascades converge and are controlled at the level of intracellular trafficking, but the mechanisms by which myogenesis is regulated by the endosomal machinery and trafficking is largely unexplored. The Endosomal Sorting Complex Required for Transport (ESCRT) machinery composed of four complexes ESCRT-0 to ESCRT-III regulates the biogenesis and trafficking of endosomes as well as the associated signaling and degradation pathways. Here, we investigate its role in regulating myogenesis. RESULTS: We uncovered a new function of the ESCRT-0 hepatocyte growth factor-regulated tyrosine kinase substrate Hrs/Hgs component in the regulation of myogenesis. Hrs depletion strongly impairs the differentiation of murine and human myoblasts. In the C2C12 murine myogenic cell line, inhibition of differentiation was attributed to impaired MRF in the early steps of differentiation. This alteration is associated with an upregulation of the MEK/ERK signaling pathway and a downregulation of the Akt2 signaling both leading to the inhibition of differentiation. The myogenic repressors FOXO1 as well as GSK3β were also found to be both activated when Hrs was absent. Inhibition of the MEK/ERK pathway or of GSK3β by the U0126 or azakenpaullone compounds respectively significantly restores the impaired differentiation observed in Hrs-depleted cells. In addition, functional autophagy that is required for myogenesis was also found to be strongly inhibited. CONCLUSIONS: We show for the first time that Hrs/Hgs is a master regulator that modulates myogenesis at different levels through the control of trafficking, signaling, and degradation pathways. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-021-01091-4. BioMed Central 2021-07-30 /pmc/articles/PMC8323235/ /pubmed/34330273 http://dx.doi.org/10.1186/s12915-021-01091-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Coudert, L.
Osseni, A.
Gangloff, Y. G.
Schaeffer, L.
Leblanc, P.
The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
title The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
title_full The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
title_fullStr The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
title_full_unstemmed The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
title_short The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
title_sort escrt-0 subcomplex component hrs/hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323235/
https://www.ncbi.nlm.nih.gov/pubmed/34330273
http://dx.doi.org/10.1186/s12915-021-01091-4
work_keys_str_mv AT coudertl theescrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT ossenia theescrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT gangloffyg theescrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT schaefferl theescrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT leblancp theescrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT coudertl escrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT ossenia escrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT gangloffyg escrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT schaefferl escrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways
AT leblancp escrt0subcomplexcomponenthrshgsisamasterregulatorofmyogenesisviamodulationofsignalinganddegradationpathways